Algo version: 0.98b
NVIV is listed at the NASDAQ Exchange
NVIV [NVIV]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is NVIV stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for InVivo Therapeutics 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $38 250, you would have made a loss of $-38 250 per share or -100.00%

Yes, the average daily trading liquidity for InVivo Therapeutics is $1.25 million. You should therefore be able to get in and out of your positions relatively fast.

InVivo Therapeutics has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for InVivo Therapeutics to be medium [0.6 out of 1]